Imaging plays a central role in cancer diagnosis, therapy, and prognosis primarily through the depiction of anatomically defined abnormalities. With the wealth of information provided by the maturing fields of genomics and proteomics, the identification of molecular markers and targets promises contrast material-enhanced diagnostic imaging with specificity and sensitivity that is not otherwise possible with conventional anatomic imaging (1) . If measurement approaches can result in the acquisition of signals from micromolar or smaller amounts of contrast agents within clinically relevant volumes, molecular imaging promises to improve diagnostic imaging and to affect the quality of care for patients with cancer.
Near-infrared (NIR) light between the wavelengths of 700 and 900 nm propagates deeply through tissues and provides a unique approach for molecularly based diagnostic imaging. With NIR-excitable fluorescent contrast agents that can be conveniently conjugated with a targeting or reporting moiety, there is clinical opportunity (yet unproved) for using nonionizing radiation with these nonradioactive contrast agents for "homing in on" early
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metastatic lesions, performing sentinel lymph node mapping, and following the progress of therapy. Furthermore, if one conducts measurements with emerging time-dependent techniques in which fluorescent decay processes are measured, the ability to employ activate-able fluorescent contrast agents and to tomographically reconstruct three-dimensional (3D) in vivo maps of diseased tissue may be possible. To date, limited progress toward 3D tomographic fluorescence-enhanced optical imaging has been demonstrated in phantom-based and small animalbased studies (2) (3) (4) (5) (6) .
The translation of fluorescence-enhanced optical imaging to the clinic is made possible by the availability of indocyanine green (ICG), with its established record of nontoxicity and patient safety for the indications of evaluating hepatic function (7) and retinal angiography (8) , as a potential NIR fluorescent contrast agent. However, before ICG can be used in fluorescence-enhanced optical imaging, tissue phantom studies must be performed to demonstrate the possible benefits. The purpose of our study was to demonstrate the feasibility of reconstructing single and multiple targets by using fluorescence-enhanced tomography of a breast-shaped phantom.
MATERIALS AND METHODS

Phantoms
A cup-shaped phantom (10-cm-diameter hemisphere, 262-cm 3 volume) filled with a fatty emulsion liquid (1% Liposyn; Abbott Laboratories, North Chicago, Ill) was used to mimic the breast tissue (Fig  1) . The extended 20-cm-diameter cylindric portion of the breast phantom (825-cm 3 volume) represented the chest wall regions around the breast tissue.
Measurements for image reconstruction were performed by using single or multiple 0.5-1.0-cm 3 targets (transparent cubical cuvettes or hand-blown glass spheres filled with appropriate concentrations of the fluorescing contrast agent in 1% Liposyn solution) that were located at different depths and target-tobackground (T:B) contrast ratios, as listed in Table 1 . In the first three experiments, 1 mol/L of ICG (Cardio-Green; Akorn, Buffalo Grove, Ill) in 1% Liposyn solution was used in the target, and 0.01 mol/L of ICG was used in the background, which contained 1% Liposyn, to mimic tissue scattering properties. In other words, in the first three experiments, an imperfect uptake (T:B contrast ratio, 100:1) of the fluorescing contrast agent by the target was assumed. For the fourth experiment, three approximately 0.55-cm 3 targets containing 2.5 mol/L of ICG were positioned within the phantom, which contained no ICG; hence, with this situation, a perfect uptake (T:B contrast ratio, 1:0) of the contrast agent was assumed. ICG excites at 780 nm and emits at 830 nm; it has a fluorescent lifetime of 0.56 nsec and a quantum efficiency of 0.016 (9) .
Frequency-Domain Photon Migration Measurements
Time-dependent measurements of fluorescent light propagation and generation were made by using frequency-domain techniques. Briefly, this method depends on illuminating the phantom with intensity-modulated excitation light and detecting the phase delay and amplitude attenuation of the generated fluorescent light relative to the phase delay and amplitude of the incident excitation light. The phase delay is effectively a measurement of the mean total time of light propagation and fluorescence generation. The phantom surfaces were sequentially illuminated at single point positions on the phantom surface with intensity-modulated excitation light (783 nm at a 100-MHz modulation frequency) by using 1000-m-diameter optical fibers to deliver the light. The fluorescent signal (830 nm) was collected from point locations on the phantom surface through the 1000-m-diameter optical fibers and by using interference (830 nm) and holographic (780 nm) filters to block the excitation light.
Rapid acquisition of the phase delay and amplitude modulation of the detected fluorescent light emitted from the end of each collecting fiber was simultaneously accomplished by using a gainmodulated intensified charge-coupled device (CCD) camera, which was operated in homodyne detection mode. A schematic of the frequency-domain photon migration-modulated intensified CCD camera system is provided in Figure 2 , and details pertaining to instrumentation and the data acquisition procedure are described in Appendix E1 at radiology.rsnajnls.org/cgi /content/full/234/3/148/DC1 and elsewhere (6,10 -12) . With the intensified CCD system, fluorescent boundary surface measurements of phase delay and amplitude attenuation were acquired from sparse point locations on the hemispheric surface and used along with a finite-elementbased (13) diffusion model for light propagation in tissues (14 -16) so that we could reconstruct the position of the target(s).
Reconstruction Algorithms
Three-dimensional image reconstructions of the tissue phantom were created from sparse surface measurements of the fluorescence signal emitted from the small targets that contained ICG. The unknown vector of absorption coefficient, axf , due to the presence of the fluorescing agent was reconstructed by using a recursively updating Bayesian algorithm, yielding an interior optical property map. Table 1 lists the number of paired phase-shift and amplitude attenuation measurements, as well as the number of unknowns, or vector elements of axf .
Unlike the simple back-projection schemes used in conventional computed tomographic (CT) or nuclear imaging techniques, optical image reconstructions are based on the diffusive transport of light in a highly scattering medium and require nonlinear reconstruction techniques. The reconstruction algorithm used in this study, the approximate extended Kalman filter 
Data Analysis
The sparse boundary surface fluorescence measurements, along with the measurement errors in the AEKF reconstruction algorithm, were used to reconstruct the absorption coefficient, axf , due to the fluorophore in the hemispheric portion of the 3D phantom volume. A constant value of axf , 0.003 cm
Ϫ1
, was chosen as the initial estimate of the reconstruction parameter for all the experimental cases during the image reconstructions, and the AEKF algorithm was performed iteratively with a 3.06-GHz Pentium IV machine (Xeon; Dell Computers, Dallas, Tex) to estimate the spatial distribution of axf in the phantom volume. Convergence on the final absorption image occurred when there was less than a 1% additional decrease in the root-mean-square output error.
In all of the experiments, the target was differentiated from the background tissue phantom on the basis of the first break (termed the "threshold" value) observed in the histogram distribution of the reconstructed parameter axf . The spatial distribution of the reconstructed parameter axf above the threshold value was plotted as a series of points located in 3D space in the anterior and lateral views of the 3D breast phantom by using Tecplot 9.2 software (Amtech Engineering, Bellevue, Wash).
On the basis of the threshold values in the reconstructed parameter axf , the centroid of the reconstructed target(s) and the difference between the actual and the reconstructed target positions, along with the reconstructed volume, were estimated. The difference between the actual and the reconstructed target positions was estimated as the Euclidean distance between the value-weighted centroids of the reconstructed and actual target locations. The reconstructed volume was calculated as the sum of the volumes corresponding to the nodes of the finite-element mesh that had a axf that was greater than the set threshold value.
In the case of the fourth experiment, which involved small-volume targets of approximately 0.55 cm 3 , two finite-ele- ment meshes, varying in their level of discretization (3857 and 11 906 unknowns), were used to determine the effect of discretization on image reconstruction of small-volume targets.
RESULTS
The absorption coefficient, axf , due to the fluorophore was successfully reconstructed for all of the experiments by using the AEKF reconstruction algorithm. The total reconstruction time was a function of the total number of measurements and the finite-element mesh discretization and varied nonlinearly with respect to these numbers of knowns and unknowns, respectively. On average, each iteration required 5-7 minutes when the number of unknowns was 3857. However, when a finely discretized mesh with 11 906 unknowns was used in the fourth experiment, each iteration required approximately 15 minutes. The reconstruction times and numbers of iterations required for convergence are tabulated in Table 2 . Anterior and lateral views of the tissue phantom containing the true and reconstructed targets in the four experimental cases are shown in Figures 3-6 as the spatial distribution of nodal points in which the reconstructed parameter axf was above the threshold value. Estimates of the target centroid locations with respect to the actual centroid locations, the reconstructed target volume, and the difference between the actual and reconstructed target positions are provided in Table 3 . The volume of the reconstructed target was sensitive to the threshold value of the reconstructed parameter, although there was a minimum effect of the threshold value on the reconstructed target's centroid location.
Although the volume of the actual target(s) comprised 0.6% or less of the total volume that was tomographically imaged, the target(s) was reconstructed close to its true location(s) with minimal or no artifacts, as shown in Figures 3-6 and quantified in Table 3 . However, in the imperfect-uptake experiments (ie, those in which the T:B ratio was 100:1), the reconstructed depth of the target was underestimated as the actual depth of the target increased.
The effect of discretization of the finite-element mesh in the reconstruction of the tissue phantom is shown in Figures  6 and 7 for the fourth experiment, which involved small-volume and multiple targets in conditions of perfect uptake (T:B ratio, 1:0). Figures 6 and 7 show anterior and lateral views of the reconstructed Table 3 . The reconstructions of the small-volume multiple targets that were performed by using the finite-element mesh with 3857 unknowns did not yield distinctly reconstructed targets.
DISCUSSION
Unlike the situation with conventional nuclear imaging, magnetic resonance imaging, positron emission tomography, and CT, the translation of NIR optical imaging with fluorescent contrast agents from the laboratory to the clinic requires the simultaneous introduction of both new investigational imaging agents and a new investigational imaging device. Questions regarding (a) the ability of this method to enable detection of the small fluorescent signals generated from deeply located targets at the tissue surface, (b) the influence of measurement noise on tomographic image reconstruction algorithms, and (c) the local quantities of the contrast agent required for enhancement need to be assessed in phantoms with clinically relevant sizes before clinical translation can be attempted. The results of our study demonstrate the feasibility of optical tomographic imaging of single and multiple fluorescently contrasted lesions by using surface measurements of re-emitted fluorescent light generated by a micromolar concentration of ICG, an agent with Food and Drug Administration approval for the indications of assessing hepatic function and retinopathy.
Currently, several limitations hinder the capabilities of fluorescence-enhanced optical tomography. First and foremost, the "noise floor" attributable to excitation light leakage through the rejection filters remains the critical factor for increasing the penetration depth and reducing the contrast or amount of contrast agent required for target detection. For example, the excitation light that reaches the end of a fiber optic is at least three or four orders of magnitude higher than the fluorescent signal collected in our experiments. Rejection of excitation light with interference filters with "typical" optical densities of 4 or 5 will result in a high noise floor and limit the sensitivity of detecting deep or weakly fluorescing lesions.
While the use of frequency-domain photon migration measurements alleviates the noise floor problem due to am- (18) . However, owing to excitation light leakage through the interference filters, the weak fluorescent signal is not quantitatively accurate for tomographic image reconstruction. Advances in filter design and implementation could overcome this limitation. The final image resolution of fluorescence-enhanced imaging depends on the discretization of the finite-element mesh. One of the challenges for fluorescenceenhanced optical tomography is resolution: The greater the resolution, the greater the number of unknowns that will result, and, henceforth, the more computationally difficult the tomography problem will be. The development of tomographic imaging algorithms that are capable of handling high-spatial-resolution imaging, involving adaptive meshing and boundary element methods, may further improve computational efficiency and is currently being investigated.
The development of NIR-excitable probes conjugated to targeting ligands and reporting agents is paramount for fluorescenceenhanced molecular optical tomography. While there has been much progress in molecular imaging with nuclear techniques, fluorescent probes coupled with fluorescence-enhanced tomography may offer greater imaging sensitivity owing to the repeated activation, relaxation, and reemission of fluorescent photons by NIR fluorophores. Consequently, the use of conjugated NIR fluorophores yields improved signal-to-noise ratios as compared with the signal-to-noise ratios yielded by signal-conjugated radiotracers, which are extinguished after a single emission event. The reader is referred elsewhere for reviews of the molecularly targeting and reporting fluorescent contrast agents being developed (19 -21) .
In conclusion, in this study, 3D optical tomographic reconstructions were performed on the basis of experimental data obtained in a phantom with clinically relevant geometry that contained targets contrasted by micromolar ICG at varying depths (1.43-2.82 cm deep) or multiple 0.55-cm 3 targets located approximately 1.30 cm deep. Further work to improve depth of penetration, resolution, and imaging contrast by using improved methods for achieving excitation light rejection, as well as adaptive finite-element or boundary element methods for improved computational analysis, is underway.
These preliminary data on fluorescence-enhanced optical imaging of large breast phantoms demonstrate its potential benefit for clinical applications. Future work involves algorithm improvement of image resolution, conjugation of ICG-like molecules for molecular targeting, and improved rejection of excitation light for accurate collection of fluorescent light signals.
